Patent · US Expired

Optimized multi-epitope constructs and uses thereof

US7507803B2 · kind B2 · utility

3Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 2003
Grant dateMar 24, 2009
Priority date
Expiry dateOct 16, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2730/10134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.